{"schema_version":"secwatch.filing_event.v1","accession":"0001401914-26-000040","form_type":"8-K","ticker":"DARE","cik":"0001401914","company_name":"Dare Bioscience, Inc.","filed_at":"2026-07-17T20:07:20+00:00","discovered_at":"2026-07-17T20:08:00.631984+00:00","generated_at":"2026-07-17T20:08:06.093376+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Daré Bioscience receives Nasdaq delisting notice for equity deficiency; plans to request hearing","bullets":["Nasdaq notified Daré on July 13, 2026 that stockholders' equity was below $2.5M as of March 31, 2026.","Company also failed alternative compliance measures: $35M market value or $500K net income from continuing ops.","Daré intends to timely request a hearing before a Nasdaq Hearing Panel to stay delisting.","No assurance that the Panel will grant an extension or that the company will regain compliance.","Non-compliance is with Nasdaq Listing Rule 5550(b); delisting risk remains."],"urls":{"canonical":"https://secwatch.observer/filing/0001401914-26-000040","json":"https://secwatch.observer/filing/0001401914-26-000040.json","markdown":"https://secwatch.observer/filing/0001401914-26-000040.md","text":"https://secwatch.observer/filing/0001401914-26-000040.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401914/000140191426000040/0001401914-26-000040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401914/000140191426000040/dare-20260713.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-17T20:08:06.093376+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}